chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physical therapist concerning three female patients who on an unspecified date were vaccinated with a dose of GARDASIL (lot# not reported). It was reported that on an unspecified date, the patients were suffering from dysautonomia. At the time of the report, the patients' outcomes were unknown. It was unknown if the patient sought medical attention. Follow up information has been received from the physical therapist concerning a current 13 year old female patient who developed orthostatic hypotension, tachycardia, "tummy trouble", fainting, and chronic fatigue after she received GARDASIL (lot and date unknown). She did not go to school for long periods of time because of these symptoms. The physical therapist stated that this condition has been "life altering". At the time of this report, the patient's outcome was unknown. Orthostatic hypotension, tachycardia, "tummy trouble", fainting and chronic fatigue were considered to be disabling. This is one of several reports received from the same source. No further information is available.
experienced fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (experienced fever) in a 34-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (NO MEDICAL HISTORY REPORTED).   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 18-Mar-2021, the patient experienced PYREXIA (experienced fever). At the time of the report, PYREXIA (experienced fever) outcome was unknown. Not Provided          The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.  Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.
Local rash at injection site and 104 fever X 4 days, in left thigh. No treatment required.
eyes rolling, staring spells, status seizure: on 8/31/01, noted eyes rolling and staring spells. mid-to late July 7-14 post vaccination In ER 8/31/01, seizure lasted 40 minutes, took Versed to stop.   Per annual follow up pt has not recovered. Seizure disorder uncontrolled with medication
Pt co lightheadedness after covid vaccine.  Has waited over 15 minutes.  Reports "floaters".  Declines water.  States"  I just don't feel right".  BP 120/62, Pulse 67.  Denies difficulty breathing or diziness.  Pt taken to ER via wheelchair with wife.
Information has been received from a physician concerning a 19 year old male who on 27-FEB-1991 was vaccinated with a first dose of MMR II, site and lot number not reported. On 28-DEC-1998, the patient was vaccinated with a second dose of MMR II (route, site and lot number not reported. On 29-NOV-2009, the patient experienced mumps (date diagnosed reported as 24-DEC-2009). The patient had right parotitis and fever of 100.2 degrees F. The outcome for mumps was not reported. Follow up information has been received from the physician who reported that the patient experienced mumps on 11-NOV-2009 (also reported by the physician as: 24-DEC-2009). The patient had parotitis (also reported by physician as: right parotitis) and the patient was afebrile (also reported by physician as the patient had fever of 100.2 degrees F). On 13-NOV-2009 a laboratory blood work were performed and the results showed: serum immunoglobulin M test (Ig M) negative, serum amylase test: 567, serum immunoglobulin G test: 4. The outcome for mumps was not reported. This is one of several reports from the same source. No further information is available.
As the vaccine was being administered into my left deltoid, the vaccine hurt at the injection site and I immediately felt very strange and felt a rushing sensation to my head and throughout my body, with a concentration in my upper body.  It felt like an out of body experience: I fainted, hitting my head on the adjacent wall and fell to the ground, where the impact caused a bruise to my shoulder and back.  It was reported to me that I lost consciousness for about 10 seconds.  I felt disoriented, but lucid when I came to.  I was not exactly sure what happened, but I could feel that I hit my head on the right side and asked if I fainted since I was disoriented and on the floor.  With assistance, I was able to sit back on the bench, but felt extremely dizzy, light headed, fuzzy/strange type of blurry vision, and intense sweating.  I did not feel well and knew I would have an unsteady gait if I attempted to stand.  After about 15 minutes, I felt well enough to return home.
Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date; No adverse event; Administered the vaccine after the 30 day use by date; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) in a 73-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 058A22-2A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 22-Jul-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 22-Jul-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date), PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Administered the vaccine after the 30 day use by date) and PRODUCT STORAGE ERROR (Vial was initially stored in refrigerator on 4-Jun-2022 and administered past 30 day use by date).    No concomitant medications were reported.   The patient received half dose. The vial did not undergo any temperature excursions.  No treatment details were reported
18SEP95 pt recvd vax 1315PM & by 5PM was running T, irritable, mom began giving APAP q 4hrs; By 1830 T103 po cont crying, cried all noc; 19SEP was listless, refused to nurse, T103 w/APAP q 4 hrs; mom called PHN 20SEP
Information has been received from a physician concerning female patient in her 20's who on an unspecified date when she was 16 or 17 years old was vaccinated with the third dose in series of GARDASIL (lot number not provided). The physician stated that the patient's mother who was in the office reported that on an unspecified time the patient went to see the obstetrician-gynecologist (OB-GYN) and a Papanicolaou (PAP) smear was done which showed that the patient had abnormal cells. The physician reported that the obstetrician-gynecologist office did a scrape to remove some of the cells, but stated that the abnormal cells that the patient had were not any of the human papillomavirus types in GARDASIL. The physician reported that they were waiting to see if the patient had any more abnormal cells. At the time of the report the patient's outcome was unknown. Additional information has been requested.
Patient has a vasovagal syncope after receiving second shot of MMR. Varivax was given first and the MMR. Patient felt light headed, dizzy, and was out for 10 seconds. He then came back and felt very hot and needed to lay down. Was given some water, ice packs and was monitored for 25 minutes. He then was able to sit up and was feeling better. He stayed at the pharmacy for a bit longer and was driven home by a friend. Patient reports feeling back to normal an hour after the vaccination.
Fever (102), chills (shaking), body ache, migraine and vomiting
Vaccine rec'd for shingles protection on 9/11/12 at 1 pm. Band aid to area. By evening day 1 - bright red rash - shape to match regular single band aid appeared. Removed - sore at site. Day 2 evening - arm area swollen, bright red rash, hot to touch/ice applied. Day 3 - back of arm still swollen, hot to touch red bright rash same area, now surrounded by a circular rash going out 3-4 more inches all around it. Headache. Day 4 - off work sick- nauseated, headache, swollen, hot, extended rash continued, painful. Day 5 - outer rash diminishing, swelling down, ongoing band aid size rash, bright rash continued, no further nausea or headache. Not hot to touch. Day 6: Slightly less red - still visible at full out line of band aid area, swelling gone. Slightly painful to touch only. Not hot to touch.
Arthralgia, difficulty moving arm, myalgia, decreased sleep, headache, hypersomnia irritability, fatigue.
Head pulled to the right, decreased use of right arm, limp, generalized strength loss, decreased appetite. Symptoms started the day after immunizations and lasted 3 days (3/14/03-3/17/03). Exam was negative on 3/18/03.
Got Covid; Got Covid; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An elderly female patient received BNT162b2 (BNT162B2), in Feb2021 as dose 1, single (Batch/Lot number: unknown), in 2021 as dose 2, single (Batch/Lot number: unknown) and in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2022, outcome "recovered" and all described as "Got Covid". Patient and her husband are seniors. They both received the first dose of the Covid Vaccine Feb2021 and three weeks later got the second dose of the Covid Vaccine. They received a third dose, it was the Regular Covid Shot in Sep2021. Then, in May2022, she got Covid. After getting well they both got another Pfizer Covid Shot in Jul2022. Now she has questions about the new Covid Booster, the Omicron one, the one that just came out in the . Patient mentioned they read something about if take the Booster one can get Covid. She just wanted her questions answered because need to try and see if can get the vaccine. She was aware of the new Omicron booster dose, and she knew that she was an eligible patient to receive it. However, she wanted to know if 5 doses of the vaccine would be considered an overdose. She was wondering if a person can get "too many" COVID shots.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
PATIENT INITIALLY COMPLAINED OF DRY MOUTH, METALLIC TASTE WHICH PROGRESSED TO NUMBNESS AND TINGLING IN MOUTH AND THROAT.  PATIENT BEGAN TO FEEL DIZZY AND WAS PLACED INTO TRENDLENBERG POSITION FOR 20 MINUTES, AFTER WHICH SHE RETRUNED TO HIGH FOWLERS POSITION.  SHE CONTINUED TO COMPLAIN OF NUMBNESS AND TINGLING IN MOUTH AND THROAT AND PATIENT REQUESTED EMS BE CALLED.  PATIENT WAS NEVER IN ANY APPARENT RESPIRATORY DISTRESS, HR STRONG AND REGULAR, INITAL BLOOD PRESSURE MILDLY ELEVATED, SUBSEQUENT ONES WERE WNL.
This spontaneous report as received from a physician assistant, via company representative, refers to a female patient of unknown age. Pertinent medical history, concurrent conditions, drug reactions or allergies were unspecified. On an unknown date, approximately in October 2014 (about 6 months ago), the patient was vaccinated with a dose of ZOSTAVAX, 1 dose, 1 time (dose, dose number, route, anatomical location, lot number and expiration date were not reported). Concomitant therapies were unspecified. On approximately 21-APR-2015 (reported as: "about one week ago", "about 6 months after vaccine"), the patient experienced shingles (herpes zoster). The patient sought medical attention by visiting reporter's office and was treated with an unspecified pain medication. It was unspecified if laboratory test was performed. The outcome of herpes zoster was unknown. The relatedness between herpes zoster and ZOSTAVAX was not reported. Additional information is not expected because the reporter refused additional contact.
Fever 101; swelled, fist sized raised below the injection site which was on left thigh , 2-3 inch swell around the injection site; Red area just below the injection site whichwas on my left thigh; warm area just below the injection site whichwas on left thigh; Tender area just below the injection site whichwas on left thigh, injection site also tender to touch; Pain extends from groin area; Pain around the side of thigh, down towards knee and to the back of thigh causing difficulty, sitting, walking and moving.; Slight swelling, around the side of thigh, down towards knee and to the back of  thigh causing difficulty sitting, walking and moving.; vaccine administered in inappropriate site; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right thigh on 09Apr2021 at 08:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer in 2008 and COVID-19. The patient received unspecified medications within two weeks of vaccination. The patient has known allergy to oxycodone. Prior to the vaccination, the patient was diagnosed with COVID-19. On 09Apr2021 at 22:00 the patient experienced fever 101, had a swelled, fist sized raised, red, warm and tender area just below the injection site which was on left thigh due to a previous cancer diagnosis that was cleared. There was also a 2-3 inch swell around the injection site, tender to touch and movement. It resembled a bullseye. The pain extended from groin area with slight swelling, around the side of thigh, down towards the knee and to the back of thigh causing difficulty sitting, walking and moving. No therapeutic measures were taken for the events. The events resulted in doctor or other healthcare professional office/clinic visit.  On 09Apr2021, the patient underwent body temperature and the result was 101 (unspecified units). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event fever 101 was recovered on an unknown date in Apr2021; while that of swelled, fist sized raised, red, warm and tender area just below the injection site which was on left thigh, 2-3 inch swell around the injection site, tender to touch and movement, pain extended from  groin area with slight swelling, around the side of thigh, down towards the knee and to the back of thigh causing difficulty sitting, walking and moving was not recovered at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report as received from a Company Representative via the physician refers to an approximately 62 years old male patient. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, lot number and expiration date not provided). On an unknown date in September 2013 the patient experienced shingles. At the time of this report the patient was recovering from the event of shingles. The patient sought medical attention by the office visit. The relatedness between shingles and the vaccination with ZOSTAVAX was not reported. Additional information has been requested.
administration date: 05Feb2021/administration date:12Feb2021; administration date: 05Feb2021/administration date:12Feb2021; Severe headache; nausea; dizziness; Debilitating; I'm unable to work or care for my family; vestibular migraine; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER COVID 19) via an unspecified route of administration on the left arm on 12Feb2021 at 14:15 at the age of 41-year-old as single dose for COVID-19 immunization. Medical history included known allergy to sulfa medications. The patient didn't received other vaccine in four weeks. No known history of migraine or vestibular issues. The patient was not COVID prior vaccination. The patient was not test post vaccination. Concomitant medication included citalopram. The patient previously received the first dose of BNT162B2 via an unspecified route of administration on the left arm on 05Feb2021 at 02:15 PM at the age of 41-year-old as single dose for COVID-19 immunization. On 27Feb2021 at 12:00, the patient experienced severe headache accompanied by nausea and dizziness, debilitating, Ent said it's vestibular migraine. It's been ongoing for 10 days. Debilitating and patient was unable to work or care for my family. The events resulted in doctor or other healthcare professional office/clinic visit. Treatment included prednisone and eye exercises. The outcome of inappropriate schedule of vaccine administered and off label use was unknown. The outcome of other events was not recovered.  The lot number for BNT162B2, was not provided and will be requested during follow up.
Patient presented to the outpatient clinic on 2/2/18 for evaluation of viral URI symptoms and right-sided facial droop. On evaluation, she was found to have a right-sided hemiparesis. Fever, cough, and runny nose initially started 1/23/18, the day after immunization occurred. URI symptoms slightly improved, and then around 1/28/18, family noted right-sided facial droop and possible right-sided weakness (R arm > R leg). These symptoms stayed the same, but fevers and respiratory symptoms began again in the day or 2 prior to presentation in clinic on 2/2/18. Examination revealed right-sided hemiparesis and she was referred to the Emergency Department for evaluation by Neurology. MRI on 2/3/18 revealed a large left basal ganglia bleed.
The area where the cyst was became very agitated/much more agitated. It feels like a bad sunburn that you cannot see, shocks up my arm; The shoulder and armpit on that side also became sore and tingly; The shoulder and armpit on that side also became sore and tingly; The shoulder and armpit on that side also became sore and tingly/like someone is tingling my armpit; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration, in Arm, on an unspecified date in 2021 (at the age of 57-year-old) as DOSE 1, SINGLE and  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiration date: not reported), via an unspecified route of administration on 19Mar2021 at 19:00 as DOSE 2, SINGLE, both for covid-19 immunization. Medical history included cyst and that cyst removed from back in the fall and type 2 diabetes (controlled by diet and exercise). Concomitant medications included Inositol supplement, fish oil, vitamins. The patient had no Allergies to medications, food, or other products. No known allergies. The patient was not pregnant at time of vaccination. The patient didn't receive any other vaccines within 4 weeks prior to the COVID -19 vaccine. The Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. The patient stated that, on an unspecified date in 2021, after both doses, the area where the patient had cyst was became very agitated. The shoulder and armpit on that side also became sore and tingly.  That side that was agitated became much more agitated.  It felt like a bad sunburn that cannot see, shocks up the arm, randomly like someone is tingling on her armpit.  The patient's health provider said to just let it go and that it is just a reaction to the shot.  They examined patient but the ironic part is there is nothing to see--no rash, etc. It is over a week now and patient becoming concerned and plan to call doctor again today. The events resulted in Doctor or other healthcare professional office/clinic visit. No treatment was received for the adverse events. The outcome of the events was not recovered at time of report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
CHILLS; FEVER; HEADACHE; This spontaneous report received from a consumer concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the subject experienced chills, fever, and headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the fever, chills and headache was not reported. This report was non-serious. This case, from the same reporter is linked to 20210340596.
No additional adverse event; Vaccine T029104 / 23-FEB-2022 was administered 28-FEB-2022, five days post expiry date.; This spontaneous report was received from a nurse and refers to a unspecified age and gender patient. No information regarding the patient's medical history, previous drug reactions or allergies and concomitant medications was provided  On 28-FEB-2022, the patient was vaccinated with an expired dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live recombinant human albumin (rHA)(PROQUAD) subcutaneous injection, lot #T029104 who had been verified to be a valid number and established the same expiration date: 23-FEB-2022, administered for prophylaxis (strength, dose and route of administration were not provided) (expired vaccine used). No additional adverse event.
This spontaneous report was received from a health care worker refers to unspecified number of patients of unknown age and gender. No medical history or concomitant medications were reported. On an unknown date the patients were vaccinated with improperly stored doses of GARDASIL (lot number-L013429, expiry date-21-JUL-2017 and lot number-K010215, expiry date-05-MAY-2017, Lot number-K011562, expiry date-08-APR-2017, dosing regimen unknown). No adverse events were reported. No laboratory tests were reported. No product quality complaint (PQC) was involved. The outcome of the events was unknown. The reporter considered events to be not related to GARDASIL. This is one of several reports received from the same reporter. Additional information is not expected, no contact details were provided.